Skip to Content

Moderna begins study of COVID-19 vaccine in children younger than 12

CAMBRIDGE, Mass. — Moderna announced Tuesday it is beginning a study of its COVID-19 vaccine in children younger than 12 — one that will include babies as young as 6 months.

The announcement comes exactly a year after the first adult received a test dose of the shot, created at the National Institutes of Health. It’s now being used across the U.S. and in multiple other countries.

25 News Coronavirus Vaccine Information Page

Moderna also has tested the vaccine in 12- to 17-year-olds but hasn’t yet released the findings.

The study in younger children will be more complex, because researcher need to determine whether to us smaller doses than in adults and adolescents.

The study aims to eventually enroll about 6,750 children in the U.S. and Canada. That’s after a phase-in portion to determine the best dose to test in children age 2 and older and the right dose in those younger than 2.

Coronavirus resources

  • Click here for the latest CDC novel coronavirus resources and links.
  • Track the COVID-19 globally using this map tracker here.
  • You can view the latest Illinois COVID-19 numbers here.
  • For mobile testing site locations, click here.
  • You can catch up on the latest 25 News coronavirus coverage here.
  • Sign up here for the latest local, state and national news, and weather updates.
Author Profile Photo

WKOW

Skip to content